The b-adrenergic receptor (bAR) genes are candidate genes for obesity because of their roles in energy homeostasis and promotion of lipolysis in human adipose tissue. Objective is to determine the association between obesity and polymorphisms in genes of the b 1 AR (ADRB1), b 2 AR (ADRB2), b 3 AR (ADRB3), Gs protein alpha (GNAS1), to which all three b-receptors couple and the G protein b3 subunit (GNB3), to which b 3 ARs couple. DESIGN: A case-control genetic association study. SUBJECTS: A total of 643 black or white women enrolled in Women's Ischemia Syndrome Evaluation (WISE) study. MEASUREMENTS: Genotypes were determined by PCR with single primer extension. Associations between genotype and body mass index (BMI), waist-to-hip ratio (WHR), waist circumference, and obesity were made. RESULTS: Polymorphisms in the three bAR genes, GNAS1, and GNB3 were not associated with BMI, WHR, waist circumference, or obesity. Linear and logistic regression analyses found no contribution of either genotype or haplotype with anthropometric measurements or obesity. CONCLUSIONS: Our study suggests that among American women with suspected coronary heart disease, polymorphisms in the bARs and their G-protein-coupled receptors do not contribute to increased BMI, WHR, waist circumference, or obesity. Given that 50% of all women die from coronary heart disease, and a higher percentage have heart disease during their lifetime, our results are likely generalizable to many American women.
Introduction
Obesity is a major health problem that has been identified as a risk factor for hypertension, coronary heart disease, dyslipidemia, type 2 diabetes mellitus, stroke, and heart failure. 1, 2 Furthermore, the cancer death rate and risk of allcause mortality rises sharply with increased body weight. 3, 4 In the US alone, one-third of adults are obese (body mass index (BMI) Z30 kg/m 2 ), and two-thirds are overweight (BMIZ25 kg/m 2 ). 5 The prevalence of obesity among middle-aged US women has more than doubled in the last 40 years (15.7-34%). 5 Among US adults, black (non-Hispanic)
women have the highest prevalence of overweight (78%) and obesity (50%). 5 Currently, obesity is the second leading cause of preventable death in the US, resulting in more than 300 000 deaths per year. 6 Indisputably, obesity has a heritable contribution, with estimates that 30-70% of the variability in body weight is genetically mediated. 7, 8 Obesity is the consequence of a long-term imbalance between energy intake and energy expenditure. All three known b-adrenergic receptors (bARs) are expressed in human adipocytes where they regulate energy expenditure by stimulating lipolysis and thermogenesis through augmented adenylyl cyclase activity. 9, 10 Thus, these genes represent candidate genes that may contribute to obesity. Several functional polymorphisms occur within the coding region of the bAR receptor genes and their G-proteincoupled receptors [11] [12] [13] [14] [15] [16] and some have been associated with alterations in lipolysis and thermogenesis. 17, 18 Numerous studies have investigated the association between polymorphisms in the bAR genes with anthropometric measurements and the prevalence of obesity. Unfortunately, most of these studies have focused on polymorphisms within a single gene, and not surprisingly the results of these studies have not been uniform. Association studies of a single gene may lack sufficient predictive utility for a polygenic phenotype such as obesity. To obviate the limitation of previous single gene association studies, we studied the association between obesity and genes of the b 1 AR (ADRB1), b 2 AR (ADRB2), b 3 AR (ADRB3), Gs protein alpha (GNAS1), to which all three b-receptors couple and the G protein b3 subunit (GNB3), to which b 3 ARs couple. The specific polymorphisms that were studied are listed in Table 1 . Furthermore, as the ADRB2 polymorphisms are well known to be in linkage disequilibrium, 19 we tested for linkage disequilibrium in all three of our genes where multiple SNPs were included. When LD was present, we performed analyses based on both genotype and haplotype. Given the contribution of obesity to innumerable health risks, identifying genetic factors that predispose to obesity would have enormous public health consequences.
Methods
This study was conducted using the genetics and clinical database from the Women's Ischemia Syndrome Evaluation (WISE) study. The WISE study is a National Heart, Lung, and Blood Institute-sponsored, four-center study designed to improve coronary heart disease recognition and evaluation in women. Women were eligible for the study if they were older than 18 y of age and were referred for a coronary angiogram to evaluate suspected coronary heart disease. 20 All women provided written informed consent that was approved by the IRB at their local WISE study center. In all, 643 women (105 black and 538 white subjects) were enrolled in the main WISE study with baseline and angiography results and genetic samples. Only black or white women were included in the present analyses as other racial groups were present in too small a number for any meaningful analysis.
Genotypes were determined in all 643 women. Among those who provided a genetic sample, BMI was determined at baseline in 634 black or white women and WHR was assessed in 557 women. This group of women was used in the obesity association analysis. BMI was calculated as the weight in kilograms divided by the square of height in meters. Patients 21 Physical activity was determined through the Postmenopausal Estrogen and Progesterone Intervention questionnaire (PEPI-Q). 21 The scores on the PEPI-Q range from 1-12, with higher scores indicating higher levels of physical activity. Functional capacity was assessed through the Duke Activity Status Index (DASI) questionnaire. 21 The range of DASI scores is 0-58.2, with higher scores indicating higher functioning status. 21 Genotypes were determined using Orchid BioScience's Inc. proprietary primer extension technology (SNP-ITt), which employed appropriate controls for accuracy. Allele frequencies were determined via gene counting.
Statistical analysis
Linkage disequilibrium analysis. We were interested in determining linkage disequilibrium (LD) and computationally derived haplotypes for this study for several reasons. First, the degree of LD for the GNAS SNPs, if any, has not been described, and that for ADRB1 had not been described at the time our work began. Further, we sought to determine whether haplotype analysis provided insights additional to that of single SNPs. The estimation of LD between pairs of sites, A with alleles A and a, and b with two alleles B and b, in candidate genes included two successive steps: (1) obtaining maximum likelihood estimates (MLEs) of haplotype frequencies (p AB , p aB and p ab ) using explicit expressions, and (2) solving a group of regular equations:
To obtain the MLEs of allele frequencies p A and p B and the coefficients of LD D, the statistical significance of the estimated LD was tested by calculating the log-likelihood ratio (LR) between the full model (there is a LD) and the reduced model (there is no LD . We could detect smaller weight differences with equal power in those polymorphisms with higher variant allele frequencies. Baseline characteristics were compared between races using w 2 or Fisher's exact tests as appropriate for categorical data and Student's unpaired t-test for continuous variables. The Wilcoxin-Rank Sum test was used for data that were not normally distributed. For the primary analysis, BMI was considered as a continuous variable and was compared between genotypes using a two-sample t-test or ANOVA. As a planned secondary analysis, obesity was considered a categorical variable. For this analysis, obesity was defined using the World Health Organization criterion of Z30 kg/m 2 . 24 To minimize effects of population stratification confounding the results, only white and black women were included and the previously described analyses were done separately for each race. Linear and logistic regression models were developed to examine the contributions of genotype and baseline demographic factors with BMI, and obesity, respectively. For the logistic regression model, the dependent variable was obesity as defined above. Modeling used data from both races, with variables for race, race by risk factor and race by genetic component (allele or haplotype) interactions considered for inclusion to account for race differences. In order to minimize the contribution of any regional differences in population admixture, the study center from which the patient was enrolled was one of the independent variables in the regression analysis. In the linear regression models, highest r squared analysis was used to aid in variable selection. Owing to the missing values and varying sample sizes, several candidate models were individually evaluated to arrive at a reasonable model. In the logistic regression modeling of obesity, a forward selection procedure was used to aid in model selection. For both outcome variables, variables included for selection were age, race, history of hypertension, history of dyslypidemia, history of diabetes, use of b-blocker medication, ever pregnant, ever live birth, post menopausal, DASI score, PEPI-Q score, WISE site location (sites 1-4), all polymorphism alleles and haplotype data. All statistical analyses were performed using SAS (version 8, SAS Institute Inc., Cary, NC, USA). To minimize the effect of multiple comparisons, a P-value of o0.01 was considered statistically significant; this was determined by dividing the traditional value of 0.05 by five, given that five genes were studied in this analysis. For either race, those polymorphisms that resulted in a variant homozygous genotype frequency of o2% were combined with the heterozygotes for analysis.
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Results
Allele frequencies for the studied genes are shown in Table 1 , as are comparisons between black and white subjects. With the exception of the ADRB3 codon 64 SNP, all SNPs exhibited significant differences between black and white subjects. Resulting haplotypes for the three genes with multiple SNPs are shown in Table 2 and the assessment for significant linkage disequilibrium is shown in Table 3 . Consistent with previous studies, the ADRB1 and ADRB2 SNPs were in significant LD. Of note, the ADRB1 Gly49-Gly389 allele was not observed in the 1286 alleles tested. Similarly, ADRB2 alleles containing 5 0 LCCys19 and Glu27, 5 0 LCArg19 and Arg16, and Arg16 and Glu27 were not observed. There was no significant LD noted for GNAS1, by our prespecified significant P-value of o0.01. As such, the primary obesity analyses for ADRB1 and ADRB2 were done by haplotype, whereas that for GNAS1 was done with the individual SNPs.
The clinical characteristics of the study participants by race are listed in Table 4 . More black women were obese compared to white women (P ¼ 0.0003) and black women had a significantly higher mean BMI compared to white women. White women had significantly higher measures of physical activity and functional capacity as measured by the PEPI-Q and DASI scores.
There were no statistically significant differences in BMI, waist circumference, WHR or obesity prevalence between any of the genotypes tested. Among white women, the values of BMI were essentially identical between all , which was observed for ADRB2 (Gly16Gly4Arg16Arg; P ¼ 0.26) and in the GNB3 (825TT4825 CC or CT; P ¼ 0.66).
Although none of the differences for BMI by genotype in black women reached statistical significance, there were several trends that were noted in this smaller population (Tables 5-7) . Black women with either the codon 131 CC or CT genotypes of the GNAS1 gene had a nominally higher BMI than TT homozygotes (Table 5) . Similarly black women who were ADRB3 Trp64 homozygotes tended to have a higher BMI than Arg64 carriers (Table 5) . Black women who were ADRB1 Gly389 homozygotes exhibited a 3.9 kg/m 2 greater BMI than Arg389 homozygotes (P ¼ 0.19). A similar trend towards a higher BMI was also observed in black women who were CC homozygotes compared to TT homozygotes at codon 825 of the GNB3 gene (Table 5 ). There were no differences in obesity prevalence, WHR, or waist circumference for any genotype tested in black women. b-Adrenergic receptor and G-protein polymorphisms and obesity SG Terra et al Tables 6 and 7 contain the results of the ADRB1 and ADRB2 haplotype analysis. Similar to the genotype analysis, there were no statistically significant differences in BMI, obesity prevalence, WHR, or waist circumference between subjects with different numbers of haplotype copies.
The best regression models for BMI only accounted for approximately 13% of its variability. Variables included in the final model (parameter estimate, P-value) were: age (À0.07, 0.0014), history of hypertension (1.79, 0.0011), history of diabetes (2.52, o0.0001), center 3 (2.31, 0.0002), b-blocker use (À1.44, 0.0071), and the interaction term, black Â PEPI-Q (0.33, 0.0043). Importantly, no genotype or haplotype variable entered this model. The logistic regression analysis identified five factors that were significantly associated with obesity. These were a history of hypertension, history of diabetes, enrollment from center 3, previous pregnancy, and the interaction term black x PEPI-Q score (Table 8) . No genotype or haplotype, or combination thereof, was a significant predictor of obesity in the logistic regression analysis.
Discussion
To our knowledge, this is the first obesity association study that simultaneously investigated genetic polymorphisms in all three b-AR genes and their G-protein-coupled receptors. Despite these attributes, we did not find any association between polymorphisms in the b-AR genes or their Gprotein-coupled receptors with differences in BMI, WHR, or obesity in a large cohort of white or black American women.
A review of obesity association studies involving polymorphisms in the b-AR genes reveals numerous conflicting results. This is perhaps best illustrated by the results of two meta-analyses of the Trp64Arg polymorphism in the ADRB3 gene, which arrived at different conclusions on the association with obesity. 25, 26 The results of many genetic association studies appear to depend on the ethnicity of the population under study. In humans, the ADRB2 is the main adrenergic receptor involved in mediating catecholamine-induced lipolysis and ADRB2-mediated metabolic effects are attenuated in obese subjects. 27 A study in Swedish women demonstrated that the Glu27 allele was associated with obesity. 18 Subjects with the Glu27Glu genotype had a higher BMI (38.2 vs 30.7 kg/m 2 ), larger fat cells and were more likely to be obese than subjects with the Gln27Gln genotype. The Glu27 allele has also been associated with a higher BMI and obesity among Spanish and Japanese women. 28, 29 However, an association with BMI was not observed in either Austrian or French women. 30 ,31 Yet another study found that French men with the Gln27Gln genotype had a higher body weight, BMI, WHR and increased prevalence of obesity. 31 One tenable hypothesis to explain the disparate results relates to the heterogeneity of the populations under study. A particular genotype may be associated with a phenotype in one racial/ethnic group, while not influencing the same phenotype of another population. This disparity might be due to unmeasured genetic and/or environmental factors, causing polymorphisms to have different penetrance in dissimilar ethnic groups. In the current study, the fact that certain polymorphisms showed statistical trends in blacks (despite a very b-Adrenergic receptor and G-protein polymorphisms and obesity SG Terra et al small population) and no evidence for association in whites, further supports the contention that genes that contribute to susceptibility to obesity may differ among ethnic populations.
There are fewer association studies of b-AR receptor genes and obesity published in American populations compared to other ethnic groups or nationalities. It is unclear if the fewer publications in American populations are the result of a publication bias towards 'negative' studies, or that the studies simply have not been done. A study of over 600 African Americans failed to demonstrate an association between the Arg64 allele of the ADRB3 with prevalence of obesity or obesity-related traits.
14 Another study of 550
premenopausal American women also did not find any association between the ADRB3 Trp64Arg and weight differences. 32 Additionally, a study of three microsatellite polymorphisms near the ADRB3 gene failed to demonstrate any association with BMI or WHR in North American white men and women. 33 Furthermore, in the same study the BMI was not significantly different between Trp64 homozygotes and Arg64 carriers. 33 In our review of the literature we could only find two publications of a North American population that found an association between polymorphisms in the b-AR genes or their G-protein-coupled receptors with BMI or obesity. Investigators from Vermont reported that Caucasian women with at least one Arg389 allele had a statistically greater BMI compared to Gly389 homozygotes. 34 In that study, each Arg389 allele of the ADRB1 was associated with an increase BMI of 0.86 kg/m 2 (P ¼ 0.05). Furthermore, 67%
of Arg389 carriers were obese (BMIZ30 kg/m 2 ) compared to 53% of women who were Gly389 homozygotes (P ¼ 0.03). However, these investigators did not find any difference between b 1 genotypes in adjusted resting metabolic rate, VO 2max , or energy intake. Thus, the mechanism responsible for the observed increased BMI among Arg389 carriers in that study remains speculative. In a longitudinal study in Louisiana, BMI increased at a significantly greater rate (0.4%/y) in males who were Gly16 carriers compared to Arg16 homozygotes of ADRB2. 35 This translated to an 8%
higher BMI in Gly16 carriers by the age of 32 y. No genotypeassociated change in BMI over time was observed in female subjects. 35 Another factor potentially contributing to the disparity in the ADRB2 literature is the failure to focus on haplotype. For example, in determining the response to bronchodilatory response to albuterol, investigators found no association with ADRB2 genotype, but did observe an association with ADRB2 haplotype. 20 Moreover, even when an association with genotype is noted, the haplotype is often a more robust predictor of a phenotype. 36 In the present study, there was no association between any of the ADRB1 and ADRB2 haplotypes with obesity or BMI. Yet another variable that may explain the disparate results in the b-AR polymorphism obesity literature is the failure to account for important environmental influences such as physical activity. For example, in the study of French men described earlier, the Gln27 allele was only associated with BMI, WHR, and obesity in men who did not partake in regular physical activity. 37 Another study of the GNB3 codon 825 polymorphism found that primiparous women with the TT genotype had a statistically significantly higher BMI than women who carried at least one 825C allele. 16 However, the association between the 825TT genotype with a higher BMI was evident only among women who performed less than 1 h per week of physical activity. Similarly, the Arg64 allele of the ADRB3 was significantly associated with obesity among sedentary, but not among active individuals. 38 Thus, the failure to consistently account and control for physical activity may be another confounding variable to explain the inconsistent results in the obesity association literature. In our regression analysis, enrollment from WISE site 3 (University of Florida) was significantly associated with increased BMI and obesity. Although we cannot explain this finding, it underscores the importance of environment on obesity. Moreover, the interaction of black race with baseline PEPI-Q score, a measure of functional capacity, was also significantly predictive of higher BMI and obesity, suggesting that in black women, more exercise paradoxically led to a higher BMI and higher likelihood of obesity. The reasons for this finding are unclear. As expected, our regression analysis demonstrated a strong association between obesity, hypertension, and diabetes mellitus, suggesting that the models that we used were valid.
Finally, another potential reason for the negative findings in our study is that the b-ARs and their G-protein-coupled polymorphisms might contribute only minimally to BMI and obesity, in a population of white and black American women. As such, environmental or other genetic factors could obscure genetic associations that might be noted in younger populations. Thus, the impact of these polymorphisms may be so small that studies with conventional sample sizes lack the statistical power to identify any genetic association. For example, a meta-analysis revealed a statistically significant association between the ADRB3 Trp64Arg polymorphism with BMI. Subjects who carried the Arg64 allele had an average increase in BMI of 0.30 kg/m 2 (95% CI, 0.13-0.47 kg/m 2 ). 25 This modicum of an effect, which may not be clinically relevant, was observed in a sample of 49000 subjects. Among the white women studied, BMI was nearly identical between all genotypes and haplotypes tested, suggesting that polymorphisms in b-AR and their Gprotein-coupled receptors do not predispose white American women to obesity. It is possible that a larger cohort of black women may have resulted in significant findings particularly for the polymorphisms at codon 131 of GNAS1, codon 64 of ADRB3, and codon 389 of ADRB1. Further studies to examine the effect of these polymorphisms on weight-related measurements in black subjects will be important.
An alternative study design would be to recruit subjects at the extremes of BMI (eg o23 and 430 kg/m 2 ) who are otherwise healthy, then compare allele and genotype b-Adrenergic receptor and G-protein polymorphisms and obesity SG Terra et al frequencies in these two distinct groups. Selecting healthy individuals with extremes of weight may make it easier to control for, or exclude confounding variables and consequently detect a genotype effect. Nonetheless, the design of our current study enhances the generalizability of our findings to a population of American black and white women with suspected coronary heart disease. Another limitation of the present study is that it was performed on an existing database, thus we were unable to measure certain adipocyte-derived markers that might be of interest such as leptin, resistin, or adiponectin. In summary, our study demonstrates that among American women with suspected coronary heart disease, genotypes in the bAR genes and their G-protein-coupled receptors do not contribute to increased BMI or obesity. Given that 50% of all women die from coronary heart disease, and a higher percentage have heart disease during their lifetime, our results are likely generalizable to a majority of American women. Definitive assessment in black women requires further study with larger sample sizes.
